Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, June 1, 2025, the moon is 5 days old and is in the Waxing Crescent phase of its lunar ...

Associations between acupuncture and uses of opioids and neuropsychiatric medication following chemotherapy-induced peripheral neuropathy among patients with breast cancer. Pool analysis of Part A ...